Background Image
Table of Contents Table of Contents
Previous Page  30 / 70 Next Page
Information
Show Menu
Previous Page 30 / 70 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016

300

AFRICA

higher than in patients with both valvular and congenital heart

disease.

7

Namiki

et al

.

8

reported that endothelin-1 concentrations

in the pericardial fluid were more elevated in patients with

ischaemic heart disease than in those with non-ischaemic

heart disease. In addition, Ege

et al

.

9

reported that levels

of IL-2R, IL-6, IL-8 and TNF-

α

in pericardial fluid were

significantly higher than in the serum in patients with MI. The

pericardial fluid is partially formed from cardiac interstitial fluid,

which migrates through the epicardium,

10

therefore vasoactive

substances released into the myocardial interstitium may appear

in the pericardial fluid.

6

Although levels of pro-inflammatory cytokines are well

documented in both MI and heart failure, the relationship

between cytokine levels, LV function and location of MI has not

been fully clarified. The purpose of this study was to examine the

relationship between LV function, cytokine levels and site of MI

in patients undergoing coronary artery bypass grafting (CABG).

For this purpose, the patients undergoing CABG were divided

into three groups according to the history of site of MI: anterior

MI, posterior/inferior MI and no previous MI. LV function

was analysed by transthoracic echocardiography and the levels

of adrenomedullin, TNF-

α

, IL-1

β

, IL-6 and angiotensin-II in

both the plasma and pericardial fluid were measured in these

subgroups of patients.

Methods

From September 2006 to September 2007, 60 patients who

underwent primary CABG surgery were enrolled in this

prospective study. There were 54 (90%) males and the mean age

of the patients was 60.89

±

9.39 years.

Coronary angiography and 12-lead electrocardiograms (ECG)

were performed on each patient. All patients had documented

coronary artery disease, defined as more than 75% stenosis in

one or more of the principal coronary arteries, determined by

coronary angiography.

Patients who had a recent MI in the last three weeks,

emergent operation, coronary artery re-operation, cardiogenic

shock, complications of acute MI (LV aneurysm, post-infarction

ventricular septal defect or free wall rupture), haemodynamically

significant valvular disease (severe regurgitation of more than

two degrees or severe stenosis requiring surgical intervention),

atrial fibrillation, active infectious disease, malignancies, chronic

inflammatory disease or renal dysfunction were excluded from

the study.

The baseline characteristics of the patients are shown in Table

1. Ongoing drug treatment included beta-blockers, angiotensin

converting enzyme inhibitors, nitrates, calcium channel blockers

and diuretics. All drugs were withheld on the day of the study.

According to the ECG and cardiac catheterisation findings,

patients were divided into three groups.

1

The group with no

previous MI (

n

=

20) included patients with no documented

history of transmural MI. The anterior MI group (

n

=

20)

included patients who had a total occlusion in the left anterior

descending (LAD) coronary artery or q-waves in at least two

anterior ECG leads. The posterior/inferior MI group (

n

=

20)

included patients who had a total occlusion in the right coronary

artery (RCA) or left circumflex coronary artery (LCx), or

q-waves in the posterior–inferior ECG leads.

This study was conducted in accordance with guidelines

approved by the ethics committee at our institution. Informed

consent was obtained from each participant prior to inclusion

in the study.

Standard anaesthesia and anaesthetic techniques were used

in all patients by the same anaesthesiology team. Following a

median sternotomy, the ascending aorta was cannulated for

arterial inflow and the right atrial appendage was cannulated

with a two-stage cannula for venous uptake. A cardioplegic

tack was introduced into the aortic root, proximal to the aortic

cannulation site for antegrade cardioplegic delivery. Heparin

was given at a dose of 3 mg/kg for systemic anticoagulation, and

cardiopulmonary bypass was established.

Myocardial protection was maintained initially using cold

(0–4°C) crystalloid cardioplegia solution, followed by cold blood

(10ºC) cardioplegia, and finally warm blood (37°C) cardioplegia.

Mild systemic hypothermia (32°C) was applied.

We used the left and right internal thoracic arteries and the

radial artery as arterial grafts, and the saphenous vein as venous

graft during CABG. If the left internal thoracic artery was in

optimal condition and had pulsatile flow, it was preferentially

anastomosed to the left anterior descending coronary artery.

After a median sternotomy, the mediastinal adipose tissue

and thymus were displaced from the pericardium, which was

opened and pericardial fluid was collected. Contact between the

pericardial fluid and blood was meticulously avoided.

Arterial blood samples were simultaneously withdrawn

from an intra-arterial cannula. The samples were immediately

transferred into glass tubes and centrifuged at 3 500 rpm for four

minutes. The samples were kept at –80°C for subsequent assays.

Levels of adrenomedullin, IL-6, TNF-

α

, IL-1

β

and

angiotensin-II in the plasma and pericardial fluid were measured.

Adrenomedullin levels were measured with a commercial kit

(Phoenix Pharmaceuticals Inc, CA, USA) using the enzyme

immunoassay (EIA) method. IL-6, TNF-

α

and IL-1

β

levels

were measured with commercial kits (Biosource Diagnostics,

Nivelles, Belgium) using the EIA method. Angiotensin-II levels

were measured with a commercial kit (Biosource Diagnostics,

Nivelles, Belgium) and radioimmunoassay (RIA) method.

LVfunctionwas analysed indetail inall patientspre-operatively

by transthoracic echocardiography (Vingmed System 5

Performance™, General Electric, USA). Measured indices of

LV function were LV end-diastolic diameter (LVEDD), LV

end-diastolic volume (LVEDV), LV end-diastolic volume index

(LVEDVI), LV end-systolic diameter (LVESD), LV end-systolic

volume (LVESV), LV end-systolic volume index (LVESVI),

fractional shortening (FS) and LV ejection fraction (LVEF). A

two-dimensional echocardiogram from the apical view was used

for determination of LVEF by single-plane planimetry of the left

ventricle (modified Simpson method).

Statistical analysis

For continuous variables, results are presented as mean

±

standard deviation (SD). As the values obtained were not

normally distributed, non-parametric methods were used for

tests of significance. The Kruskall–Wallis test was used to

compare the means between the three groups (no previous MI,

anterior MI and posterior/inferior MI). If this test indicated a

significant difference between the groups, the Mann–Whitney

U

-test was used to compare differences between the groups.